| Cardiovascular Products | |||||
| Sr. No | Generic Name | Composition | Ph. Ref. | Strength | |
| 1 | Torsemide Tablets IP | Each uncoated tablet contain: | |||
| Torsemide | IP | 5 mg | |||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 2 | Torsemide Tablets IP | Each uncoated tablet contain: | |||
| Torsemide | IP | 10 mg | |||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 3 | Torsemide Tablets IP | Each uncoated tablet contain: | |||
| Torsemide | IP | 20 mg | |||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 4 | Torsemide Tablets IP | Each uncoated tablet contain: | |||
| Torsemide | IP | 100 mg | |||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 5 | Rosuvastatin Tablets IP | Each film coated tablet contains: | IP | ||
| Rosuvastatin Calcium | |||||
| Equivalent to Rosuvastatin | 10 mg | ||||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 6 | Rosuvastatin Tablets IP | Each film coated tablet contains: | IP | ||
| Rosuvastatin Calcium | |||||
| Equivalent to Rosuvastatin | 20 mg | ||||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 7 | Nifedipine Tablets IP | Each uncoated tablet contains: | |||
| Nifedipine | IP | 5 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 8 | Nifedipine Tablets IP | Each uncoated tablet contains: | |||
| Nifedipine | IP | 10 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 9 | Nifedipine Prolonged-release Tablets IP | Each Prolonged- Release film coated Tablet Contains: | |||
| Nifedipine | |||||
| Excipients | IP | 10 mg | |||
| Approved Colour used | q.s. | ||||
| 10 | Nifedipine Prolonged-release Tablets IP | Each Prolonged- Release film coated Tablet Contains: | |||
| Nifedipine | |||||
| Excipients | IP | 20 mg | |||
| Approved Colour used | q.s | ||||
| 11 | Atenolol Tablets IP | Each uncoated tablet Contains: - | |||
| Atenolol | IP | 50 mg | |||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 12 | Atenolol Tablets IP | Each uncoated tablet Contains: - | |||
| Atenolol | IP | 100 mg | |||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 13 | Telmisartan | Each uncoated tablet contains: | IP | ||
| Tablets IP | Temisartan | 20 mg | |||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 14 | Telmisartan | Each uncoated tablet contains: | IP | ||
| Tablets IP | Temisartan | 40 mg | |||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 15 | Telmisartan | Each uncoated tablet contains: | IP | ||
| Tablets IP | Temisartan | 80 mg | |||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 16 | Telmisartan and | Each uncoated bilayered tablet contains: | |||
| Amlodipine | Telmisartan | IP | 40 mg | ||
| Tablets IP | Amlodipine Besilate | IP | |||
| Equivalent to Amlodipine | 5 mg | ||||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 17 | Telmisartan and | Each uncoated bilayered tablet contains: | |||
| Amlodipine | Telmisartan | IP | 80 mg | ||
| Tablets IP | Amlodipine Besilate | IP | |||
| Equivalent to Amlodipine | 10 mg | ||||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 18 | Losartan | Each film coated tablet contains: | |||
| Tablets IP | Losartan Potassium | IP | 50 mg | ||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 19 | Losartan | Each film coated tablet contains: | |||
| Tablets IP | Losartan Potassium | IP | 25 mg | ||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 20 | Losartan | Each film coated tablet contains: | |||
| Tablets IP | Losartan Potassium | IP | 100 mg | ||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 21 | Telmisartan and | Each uncoated bilayered tablet contains: | |||
| Hydrochlorothiazide | Telmisartan | IP | 40 mg | ||
| Tablets IP | Hydrochlorothiazide | IP | 12.5 mg | ||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 22 | Telmisartan and | Each uncoated bilayered tablet contains: | |||
| Hydrochlorothiazide | Telmisartan | IP | 80 mg | ||
| Tablets IP | Hydrochlorothiazide | 12.5 mg | |||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 23 | Amlodipine Tablets IP | Each uncoated tablet contains: | |||
| Amlodipine Besilate | IP | ||||
| Equivalent to Amlodipine | 5 mg | ||||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 24 | Amlodipine Tablets IP | Each uncoated tablet contains: | |||
| Amlodipine Besilate | IP | ||||
| Equivalent to Amlodipine | 10 mg | ||||
| Excipients | q.s. | ||||
| Approved Colour Used | |||||
| 25 | Atorvastatin Tablets IP | Each film coated tablet contains: | |||
| Atorvastatin Calcium | IP | ||||
| Equivalent to Atorvastatin | 10 mg | ||||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 26 | Atorvastatin Tablets IP | Each film coated tablet contains: | |||
| Atorvastatin Calcium | IP | ||||
| Equivalent to Atorvastatin | 20 mg | ||||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 27 | Atorvastatin Tablets IP | Each film coated tablet contains: | |||
| Atorvastatin Calcium | IP | ||||
| Equivalent to Atorvastatin | 40 mg | ||||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 28 | Atorvastatin Tablets IP | Each film coated tablet contains: | |||
| Atorvastatin Calcium | IP | ||||
| Equivalent to Atorvastatin | 80 mg | ||||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 29 | Atorvastatin Tablets IP | Each film coated tablet contains: | |||
| Atorvastatin Calcium | IP | ||||
| Equivalent to Atorvastatin | 5 mg | ||||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 30 | Levodopa and Carbidopa Tablets IP | Each uncoated Prolonged release tablet contains: | |||
| Levodopa | |||||
| Carbidopa (Anhydrous) | IP | 100 mg | |||
| Excipients | IP | 25 mg | |||
| Approved Colour Used | q.s. | ||||
| 31 | Levodopa and Carbidopa Tablets IP | Each uncoated Prolonged release tablet contains: | |||
| Levodopa | |||||
| Carbidopa (Anhydrous) | IP | 200 mg | |||
| Excipients | IP | 50 mg | |||
| Approved Colour Used | q.s. | ||||
| 32 | Ramipril Tablets IP | Each uncoated tablet contains: | |||
| Ramipril | IP | 1.25 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 33 | Ramipril Tablets IP | Each uncoated tablet contains: | |||
| Ramipril | IP | 2.5 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 34 | Ramipril Tablets IP | Each uncoated tablet contains: | |||
| Ramipril | IP | 5 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 35 | Ramipril Tablets IP | Each uncoated tablet contains: | |||
| Ramipril | IP | 10 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 36 | Ramipril and HydrochlorothiazideTablets IP | Each uncoated tablet contains: | |||
| Ramipril | IP | 2.5 mg | |||
| Hydrochlorothiazide | IP | 12.5 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 37 | Ramipril and HydrochlorothiazideTablets IP | Each uncoated tablet contains: | |||
| Ramipril | IP | 5 mg | |||
| Hydrochlorothiazide | IP | 25 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 38 | Metoprolol Succinate Prolonged release Tablets IP | Each film coated prolonged release tablets contains: | |||
| Metoprolol Succinate | |||||
| Equivalent to Metoprolol Tartrate | IP | ||||
| Excipients | 12.5 mg | ||||
| Approved colour used. | q.s. | ||||
| 39 | Metoprolol Succinate Prolonged release Tablets IP | Each film coated prolonged release tablets contains: | |||
| Metoprolol Succinate | |||||
| Equivalent to Metoprolol Tartrate | IP | ||||
| Excipients | 25 mg | ||||
| Approved colour used. | q.s. | ||||
| 40 | Metoprolol Succinate Prolonged release Tablets IP | Each film coated prolonged release tablets contains: | |||
| Metoprolol Succinate | |||||
| Equivalent to Metoprolol Tartrate | IP | ||||
| Excipients | 50 mg | ||||
| Approved colour used. | q.s. | ||||
| 41 | Metoprolol Succinate Prolonged release Tablets IP | Each film coated prolonged release tablets contains: | |||
| Metoprolol Succinate | |||||
| Equivalent to Metoprolol Tartrate | IP | ||||
| Excipients | 100 mg | ||||
| Approved colour used. | q.s. | ||||
| 42 | Digoxin Tablets IP | Each uncoated tablet contains: | |||
| Digoxin | IP | 0.25 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 42 | Simvastatin Tablets IP | Each film coated tablet contains: | |||
| Simvastatin | IP | 20 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 43 | Propranolol Tablets IP | Each uncoated tablet contains: | |||
| Propranolol Hydrochloride | IP | 10 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 44 | Spironolactone Tablets IP | Each uncoated tablet contains: | |||
| Spironolactone | IP | 25 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 45 | Spironolactone Tablets IP | Each uncoated tablet contains: | |||
| Spironolactone | IP | 50 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 46 | Spironolactone Tablets IP | Each uncoated tablet contains: | |||
| Spironolactone | IP | 100 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 47 | Bisoprolol Fumarate Tablets USP | Each film coated tablet contains: | |||
| Bisoprolol Fumarate | IP | 2.5 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 48 | Bisoprolol Fumarate Tablets USP | Each film coated tablet contains: | |||
| Bisoprolol Fumarate | IP | 5 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 49 | Bisoprolol Fumarate Tablets USP | Each film coated tablet contains: | |||
| Bisoprolol Fumarate | IP | 10 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 50 | Lisinopril Tablets | Each uncoated tablet contains: | |||
| IP | Lisinopril | IP | |||
| Eq. to anhydrous Lisinopril | 5 mg | ||||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 51 | Lisinopril Tablets | Each uncoated tablet contains: | |||
| IP | Lisinopril | IP | |||
| Eq. to anhydrous Lisinopril | 10 mg | ||||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 52 | Labetalol Hydrochloride Tablets IP | Each uncoated tablet contains: | |||
| Labetalol Hydrochloride | IP | 100 mg | |||
| Excipients | q.s. | ||||
| Approved colour used | |||||
| 53 | Carvedilol Tablets IP | Each uncoated tablet contains: | |||
| Carvedilol | IP | 3.125 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 54 | Carvedilol Tablets IP | Each uncoated tablet contains: | |||
| Carvedilol | IP | 6.25 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||
| 55 | Metoprolol Succinate Extended-Release, | Each film coated bilayer tablet contains: | |||
| Cilnidipine & Telmisartan Tablets | Metoprolol Succinate | IP | 23.75 mg | ||
| Eq. to Metoprolol Tartrate | 25 mg | ||||
| (As Extended-Release) | |||||
| Cilnidipine | IP | 10 mg | |||
| Telmisartan | IP | 40 mg | |||
| Excipients | q.s. | ||||
| Approved Colour used | |||||